- Home
- VNDA vs FINW Comparison
VNDA vs FINW Comparison
Compare VNDA & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- FINW
- Stock Information
- Founded
- VNDA 2002
- FINW 1999
- Country
- VNDA United States
- FINW United States
- Employees
- VNDA N/A
- FINW N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- FINW Commercial Banks
- Sector
- VNDA Health Care
- FINW Finance
- Exchange
- VNDA Nasdaq
- FINW Nasdaq
- Market Cap
- VNDA 237.9M
- FINW 192.3M
- IPO Year
- VNDA 2006
- FINW 2021
- Fundamental
- Price
- VNDA $3.95
- FINW $14.58
- Analyst Decision
- VNDA Strong Buy
- FINW Buy
- Analyst Count
- VNDA 2
- FINW 4
- Target Price
- VNDA $16.50
- FINW $20.75
- AVG Volume (30 Days)
- VNDA 471.1K
- FINW 24.7K
- Earning Date
- VNDA 05-07-2025
- FINW 04-30-2025
- Dividend Yield
- VNDA N/A
- FINW N/A
- EPS Growth
- VNDA N/A
- FINW N/A
- EPS
- VNDA N/A
- FINW 0.91
- Revenue
- VNDA $201,351,000.00
- FINW $72,056,000.00
- Revenue This Year
- VNDA $14.36
- FINW $43.72
- Revenue Next Year
- VNDA $44.53
- FINW $21.32
- P/E Ratio
- VNDA N/A
- FINW $16.22
- Revenue Growth
- VNDA 13.37
- FINW 8.59
- 52 Week Low
- VNDA $3.85
- FINW $10.02
- 52 Week High
- VNDA $6.75
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- VNDA 33.16
- FINW 43.61
- Support Level
- VNDA $4.20
- FINW $13.49
- Resistance Level
- VNDA $4.51
- FINW $14.66
- Average True Range (ATR)
- VNDA 0.18
- FINW 0.69
- MACD
- VNDA -0.02
- FINW 0.03
- Stochastic Oscillator
- VNDA 1.43
- FINW 36.56
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.